This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hedge Funds Hate These 7 Stocks -- but Should You?

Pfizer

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Shares Sold: 138.9 million
Decrease in Market Value: $8.07 billion

>>5 Stocks Poised to Pop on Bullish Earnings

Pfizer's ( PFE) positioning as one of the biggest drug makers in the world didn't spare it from institutional selling in the most recent quarter. All told, institutions sold 138.9 million shares. Like Qualcomm, that's only a dent in a very large original aggregate position, but it's still telling. It means that fund managers see a better use of capital on the market than shares of PFE.

Part of the Pfizer sale likely has to do with the anxiety over pharmaceutical firms' patent cliffs -- and the loss of Lipitor's patent protection for Pfizer specifically. While high dividend payouts were a saving grace until now, the possibility of upwardly mobile interest rates makes high yields look relatively less attractive.
5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GLD $108.62 -0.53%
ABX $6.69 -0.89%
QCOM $55.86 1.53%
ORCL $36.75 2.06%
PFE $31.97 1.95%

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs